Physician profile
Steven Dutcher
NPI 1972598464
$1,895.12
in general payments reported to CMS, 2019-2025
9 companies · $45.19 in 2025
The $45.19 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.24 · 2020: $25.99 · 2021: $92.75 · 2022: $28.81 · 2023: $1,344 · 2024: $326 · 2025: $45.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,035 · Food and Beverage: $637 · Travel and Lodging: $23.27 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,034.66 |
| Food and Beverage | $637.40 |
| Travel and Lodging | $23.27 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $1,057.93 | 2023 | |
| Medtronic, INC. | $581.47 | 2021-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray, Mazor X System |
| Orthofix Medical, INC. | $101.70 | 2020-2023 | Spinal-Stim, Spinal-Stim |
| Pfizer INC. | $53.31 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $28.40 | 2020-2022 | |
| Sanara Medtech INC. | $23.65 | 2023 | Celleraterx |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Cumberland Pharmaceuticals, INC. | $16.41 | 2021 | |
| Lenoss Medical INC | $12.25 | 2025 | Osteopearl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dutcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.